Supplementary Figure 2:
CRISPR/Cas9 targeted fushi tarazu factor 1b (ff1b) mutation in zebrafish. ff1b gRNA and Cas9 mRNA of zebrafish were synthesized in vitro, and were injected into F 0 embryos at the one-cell stage. Genomic DNA was isolated from F 0 embryos at 48 hours post-fertilization (hpf), F 1 and F 2 zebrafish at postnatal week 12. The genomic targeted region was amplified by PCR. The product was subject to T7 endonuclease I (T7EI) assay and Sanger sequencing, respectively. (A) ff1b gRNA template; (B) ff1b gRNA; (C) Cas9 mRNA; (D) the F 0 embryos analyzed by T7EI assay; (E) the F 0 mutant-type (MT) embryo verified by Sanger sequencing. The line on the top of the figure indicated the mutant region. (F) The F 1 zebrafish analyzed by T7EI assay; (G) the F 1 MT zebrafish verified by Sanger sequencing; (H) the F 2 zebrafish analyzed by T7EI assay; (I) the F 2 MT zebrafish verified by Sanger sequencing. WT: wild type; MT: mutant type. White arrows: MT was digested into two bands by T7EI assay. (J) ff1b mRNA expression in F 2 zebrafish detected by real-time reverse-transcription PCR (RT-PCR). Mean ± SD, * P<0.05, two-sided t-test, n = 3 embryos.
